Table 1

Effects of DC activation on priming of CD8+ T cell responses

Exp. (a)
DC used in priming (b)

Percent of CD8+ cells binding Flu-MP-HLA-A2 tetramer
Absolute number of Flu-MP specific cells
Fold expansion Flu-MP specific T cells

1
CD40L + IL-1β

2.39
5020
Not determined

CD40L

1.68
2900
"

Immature

0.84
1190
"

2
CD40L + IL-1β

0.28
1400
7.0

CD40L

0.24
528
2.6

Immature

0.25
656
3.3

3
CD40L + IL-1β

0.26
594
2.9

CD40L

0.14
309
1.5

Immature

0.00
0
0

4
CD40L + IL-1β
IgG
1.39
2870
19.1

CD40L
"
0.64
945
6.3

Immature
"
0.61
1130
7.5

CD40L + IL-1β
Anti-IL-12
0.57
1270
8.5

CD40L
"
0.78
1200
8.0

Immature
"
0.41
700
4.7

(a) Neonatal umbilical cord blood was used for exp. 1–3, adult mobilized peripheral blood was used in exp. 4. (b) Monocyte-derived DC cultured in GM-CSF+IL-4 were used as immature DC (unstimulated), or after activation with CD40L (1 ug/ml) or CD40L + IL-1β (1 ug/ml, 10 ng/ml respectively) for 24 hours. In experiment 4, polyclonal neutralizing Abs to IL-12 or normal goat IgG (1 μg/ml), were added at time of priming.

Wesa and Galy BMC Immunology 2002 3:14   doi:10.1186/1471-2172-3-14